Gene · 10020
Papers4,261
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,261
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serine/Threonine Protein Kinase-3 Promotes Oral Squamous Cell Carcinoma by Activating Ras-MAPK Mediated Cell Cycle Progression. | Int J Gen Med | 2023 | 37496599 | PubTator, text mining | PubMed |
| In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria. | Clin Transl Allergy | 2023 | 37488737 | PubTator, text mining | PubMed |
| Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis. | JMIR Bioinform Biotechnol | 2023 | 37485046 | PubTator, text mining | PubMed |
| Men's motivations, barriers to and aspirations for their families' health in the first 1000 days in sub-Saharan Africa: a secondary qualitative analysis. | BMJ Nutr Prev Health | 2023 | 37484540 | PubTator, text mining | PubMed |
| Toxicological assessment of pristine and degraded forms of graphene functionalized with MnOx nanoparticles using human in vitro models representing different exposure routes. | Sci Rep | 2023 | 37481626 | PubTator, text mining | PubMed |
| Statistical analysis plan for a cluster randomised trial in Madhya Pradesh, India: support to rural India's public education system and impact on numeracy and literacy scores (STRIPES2). | Trials | 2023 | 37481559 | PubTator, text mining | PubMed |
| Chemical exposure and alveolar macrophages responses: 'the role of pulmonary defense mechanism in inhalation injuries'. | BMJ Open Respir Res | 2023 | 37479504 | PubTator, text mining | PubMed |
| Identification of five novel variants of ADAR1 in dyschromatosis symmetrica hereditaria by next-generation sequencing. | Front Pediatr | 2023 | 37476031 | PubTator, text mining | PubMed |
| A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies. | Front Immunol | 2023 | 37475860 | PubTator, text mining | PubMed |
| Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington's disease. | Nat Commun | 2023 | 37468457 | PubTator, text mining | PubMed |
| Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study. | RMD Open | 2023 | 37460275 | PubTator, text mining | PubMed |
| Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool. | PLoS One | 2023 | 37459326 | PubTator, text mining | PubMed |
| Development of Assays to Measure GNE Gene Potency and Gene Replacement in Skeletal Muscle. | J Neuromuscul Dis | 2023 | 37458043 | PubTator, text mining | PubMed |
| Punishment in the public goods game is evaluated negatively irrespective of non-cooperators' motivation. | Front Psychol | 2023 | 37457072 | PubTator, text mining | PubMed |
| Our current understanding of the toxicity of altered mito-ribosomal fidelity during mitochondrial protein synthesis: What can it tell us about human disease? | Front Physiol | 2023 | 37457031 | PubTator, text mining | PubMed |
| Use of albumin infusion for cirrhosis-related complications: An international position statement. | JHEP Rep | 2023 | 37456673 | PubTator, text mining | PubMed |
| Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis. | Front Oncol | 2023 | 37456262 | PubTator, text mining | PubMed |
| Continuous vs. discontinuous purification of isolated human islets: functional and morphological comparison. | Front Endocrinol (Lausanne) | 2023 | 37455917 | PubTator, text mining | PubMed |
| Deep Characterization of a Greek Patient with Desmin-Related Myofibrillar Myopathy and Cardiomyopathy. | Int J Mol Sci | 2023 | 37446359 | PubTator, text mining | PubMed |
| Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9. | Cancers (Basel) | 2023 | 37444515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10020/papers?page=17